home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences  

Proteins & Antibodies USA Congress

  March 26, 2019  
Oxford Global, Joseph B. Martin Conference Center, 77 Avenue Louis Pasteur, Boston, Massachusetts, 02115, USA
18 - 19 November 2018

Oxford Global are proud to present the Proteins & Antibodies USA Congress, 18 - 19 November 2019, Boston, USA. Over 150 proteins, antibodies and biotherapeutics attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions.

Over 40 case studies, presentations and panel discussions focused on the key issues in protein and antibody engineering & development, antibody drug conjugates, protein & antibody biotherapeutics as well as biotherapeutics discovery & development.

View Agenda: https://bit.ly/2Yqpxpx


Including 4 interactive streams:

  • Protein Engineering Strategies, Applications, Technologies & Latest Insights
  • Biotherapeutics Discovery & Development
  • Antibody Engineering, Screening, Technologies & Current Trends
  • Protein & Antibody Biotherapeutics: Case Studies, Manufacturing, Chemistry, Analytics & Control

For further information on the congress and to receive prices and booking details, please contact me at a.saez@oxfordglobal.co.uk or call +44 (0)1865 248 455.

Live Webinar I
Targeting Bi-specific Biologics To Disease Tissues
Presented by Lorenzo Benatuil, Principal Research Scientist, AbbVie
Tuesday 3rd September 2019 | 15:00 BST

Live Webinar II
Screening Next Generation ADAPTIR Bispecific Proteins For Manufacturability & Function
Presented by David Bienvenue, Senior Director, Protein Sciences, Aptevo Therapeutics
Wednesday 4th September 2019 2019 | 15:00 BST

Organized by: Oxford Global
Invited Speakers:
  • Andreas Loew, Founder & Chief Scientific Officer, Elstar Therapeutics
  • Li Peng, Senior Vice President of Discovery & Early Product Development, Palleon Pharmaceuticals
  • Daryl Drummond, Senior Vice President & Head of Research, Merrimack Pharmaceuticals 
For the full line-up of speakers, see the agenda: https://bit.ly/2Yqpxpx
Deadline for Abstracts: N/A


E-mail: a.saez@oxfordglobal.co.uk
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.